Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

Understanding the Diagnostic Journey: MMN vs. ALS

At a Glance

Multifocal motor neuropathy (MMN) is a rare, treatable nerve disorder that causes asymmetric muscle weakness without sensory loss. Unlike ALS, MMN does not affect speaking or swallowing, lacks upper motor neuron signs, and often responds very well to IVIg treatment.

Back to Home

Navigating a diagnosis for unexplained muscle weakness can be an exhausting and frightening journey. For many people with Multifocal Motor Neuropathy (MMN), this journey—often called a “diagnostic odyssey”—is marked by significant delays and the terrifying possibility of being misdiagnosed with a more severe condition like Amyotrophic Lateral Sclerosis (ALS) [1][2].

Understanding the specific clinical signs that define MMN can help you partner with your care team to reach the correct diagnosis and begin effective treatment.

The Challenge of Rarity

MMN is an exceptionally rare immune-mediated disorder, affecting approximately 1 to 2 people per 100,000 [3][4]. Because it is so uncommon, many doctors may not see a case in their entire career. This rarity often leads to a median diagnostic delay of about 25 months [5]. During this time, more than half of patients wait over a year after their first specialist visit before receiving the correct diagnosis [2].

Why MMN is Not ALS

The most critical distinction for many patients is that MMN is not ALS. While both involve muscle weakness and wasting, they are fundamentally different diseases. MMN is a treatable condition caused by the immune system mistakenly attacking the motor nerves, whereas ALS is a rapidly progressive neurodegenerative disease [1][6].

Clinical signs that help doctors rule out ALS and confirm MMN include:

  • No Upper Motor Neuron (UMN) Signs: MMN affects only the “lower” motor nerves. It does not cause the stiff muscles (spasticity) or overactive reflexes (hyperreflexia) typically seen in ALS [7][8].
  • No Bulbar Involvement: MMN does not typically affect the muscles used for speaking, swallowing, or breathing (the bulbar muscles) [7].
  • No Trunk or Tongue Twitches: While muscle twitches (fasciculations) can occur in the limbs in MMN, they are characteristically absent in the tongue and trunk muscles, which are frequently affected in ALS [9][10].
  • Treatability: Unlike ALS, MMN often responds well to Intravenous Immunoglobulin (IVIg), which can improve strength and prevent further nerve damage [11][12].

Recognizing the Classic Presentation

MMN typically follows a specific pattern that sets it apart from other nerve disorders:

  • Asymmetric Weakness: The weakness usually begins in one limb—most often a hand or forearm—and remains uneven (asymmetric) as it progresses [6][1].
  • Purely Motor: MMN is a “pure motor” neuropathy. This means you will experience weakness without any accompanying numbness, tingling, or loss of sensation [6][13].
  • Distal Start: Symptoms usually start in the distal muscles (those furthest from the center of the body, like the fingers and wrists) rather than the shoulders or hips [6].

MMN vs. CIDP: Understanding the Difference

Doctors also distinguish MMN from Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). While both are immune-mediated, CIDP typically involves both motor and sensory nerves, meaning CIDP patients often feel numbness or “pins and needles” [6]. MMN remains focused strictly on the motor nerves that control movement.

Tools for a Clear Diagnosis

If your diagnosis is uncertain, your neurology team may use several specialized tests:

  1. Electrodiagnostic Studies (EMG/NCS): Doctors look for conduction blocks—specific spots where the electrical signal is blocked along a motor nerve, while sensory signals remain normal [6][14].
  2. Advanced Imaging: High-resolution ultrasound or MR Neurography (a specialized MRI of the nerves) can show nerve enlargement or thickening, which is common in MMN but not usually seen in ALS [15][16].
  3. Blood Tests: Testing for anti-GM1 IgM antibodies can support an MMN diagnosis, as these are present in about 40–50% of MMN patients [17]. Crucially, a negative anti-GM1 test does not mean you do not have MMN. Half of all patients with confirmed MMN will test negative for these antibodies, so they are not required for a diagnosis [18].

Reaching a diagnosis of MMN can be a long and emotional road. However, confirming MMN is a major turning point because it opens the door to effective treatments that can stabilize the disease and protect your mobility [12][19].

Common questions in this guide

How is Multifocal Motor Neuropathy (MMN) different from ALS?
MMN is an immune-mediated disorder that is highly treatable and affects only the lower motor nerves. ALS is a progressive neurodegenerative disease that typically involves upper motor neurons and the bulbar muscles used for swallowing and speaking.
Does MMN cause numbness or tingling?
No, MMN is considered a pure motor neuropathy. It causes muscle weakness but does not typically cause sensory symptoms like numbness, tingling, or loss of feeling. If sensory symptoms are present, doctors may look into other conditions like CIDP.
What tests are used to diagnose multifocal motor neuropathy?
Doctors use electrodiagnostic studies (EMG/NCS) to find conduction blocks, advanced imaging like high-resolution ultrasound or MR neurography to see nerve enlargement, and blood tests to check for anti-GM1 IgM antibodies.
Does a negative anti-GM1 test mean I do not have MMN?
No, testing negative for anti-GM1 antibodies does not rule out MMN. About half of all patients with confirmed MMN will test negative for these antibodies, so they are not required for a diagnosis.
How do doctors tell the difference between MMN and CIDP?
While both are immune-mediated nerve disorders, CIDP usually involves sensory nerves in addition to motor nerves, causing numbness or an altered sense of touch. MMN strictly affects the motor nerves that control movement.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Have you performed a thorough examination for 'upper motor neuron' signs, such as overactive reflexes or muscle stiffness, which would point away from MMN?
  2. 2.Since I have weakness in my hands/arms, did you find any evidence of 'bulbar' involvement, like weakness in my tongue or trouble swallowing?
  3. 3.Can we use high-resolution ultrasound or MRI to look for nerve enlargement to further support an MMN diagnosis?
  4. 4.If we start IVIg treatment and I improve, does that help confirm the diagnosis of MMN?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    The Potential Misdiagnosis of Multifocal Motor Neuropathy as Amyotrophic Lateral Sclerosis-A Case Series.

    Lawson V, Robbins NM

    US neurology 2018; (14(2)):102-107 doi:10.17925/usn.2018.14.2.102.

    PMID: 41583971
  2. 2

    Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey.

    Rajabally YA, Englezou C, Cluett G, et al.

    Journal of the peripheral nervous system : JPNS 2025; (30(2)):e70018 doi:10.1111/jns.70018.

    PMID: 40210218
  3. 3

    Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.

    Gentile L, Russo M, Rodolico C, et al.

    Scientific reports 2021; (11(1)):9216 doi:10.1038/s41598-021-88711-9.

    PMID: 33911162
  4. 4

    Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia.

    Park SB, Li T, Kiernan MC, et al.

    Muscle & nerve 2022; (66(5)):576-582 doi:10.1002/mus.27698.

    PMID: 36054471
  5. 5

    Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment.

    Aotsuka Y, Misawa S, Suichi T, et al.

    Muscle & nerve 2024; (70(5)):1027-1033 doi:10.1002/mus.28251.

    PMID: 39253889
  6. 6

    Multifocal Motor Neuropathy With Cranial Nerve Involvement and Vocal Cord Paralysis: A Case Report.

    Nunez MC, Nepomuceno BLM, Tiongson MLGP

    Cureus 2022; (14(5)):e25179 doi:10.7759/cureus.25179.

    PMID: 35746993
  7. 7

    Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography.

    Kronlage M, Knop KC, Schwarz D, et al.

    Radiology 2019; (292(1)):149-156 doi:10.1148/radiol.2019182538.

    PMID: 31063079
  8. 8

    Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).

    Loewenbrück KF, Liesenberg J, Dittrich M, et al.

    Journal of neurology 2016; (263(1)):35-44 doi:10.1007/s00415-015-7927-9.

    PMID: 26477025
  9. 9

    Difference in distribution of fasciculations between multifocal motor neuropathy and amyotrophic lateral sclerosis.

    Tsuji Y, Noto YI, Kitaoji T, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2020; (131(12)):2804-2808 doi:10.1016/j.clinph.2020.08.021.

    PMID: 33137570
  10. 10

    Immune-mediated neuropathies.

    Kieseier BC, Mathey EK, Sommer C, Hartung HP

    Nature reviews. Disease primers 2018; (4(1)):31 doi:10.1038/s41572-018-0027-2.

    PMID: 30310069
  11. 11

    Multifocal Motor Neuropathy: A Narrative Review.

    Claytor B, Polston D, Li Y

    Muscle & nerve 2025; (71(4)):512-534 doi:10.1002/mus.28349.

    PMID: 39936246
  12. 12

    Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy.

    Al-Zuhairy A, Jakobsen J, Krarup C

    European journal of neurology 2024; (31(7)):e16305 doi:10.1111/ene.16305.

    PMID: 38651498
  13. 13

    [Clinical and electrophysiological characteristics and therapeutic analysis of 9 patients with Lewis-Sumner syndrome].

    Sun A, Zhang Y, Liu X, et al.

    Zhonghua yi xue za zhi 2016; (96(11)):859-62 doi:10.3760/cma.j.issn.0376-2491.2016.11.007.

    PMID: 27045647
  14. 14

    Radial motor nerve conduction study in posterior interosseous nerve syndrome and multifocal motor neuropathy.

    Baima JPS, Heise CO

    Arquivos de neuro-psiquiatria 2025; (83(2)):1-5 doi:10.1055/s-0045-1806818.

    PMID: 40288409
  15. 15

    Low interrater reliability of brachial plexus MRI in chronic inflammatory neuropathies.

    van Rosmalen MHJ, Goedee HS, van der Gijp A, et al.

    Muscle & nerve 2020; (61(6)):779-783 doi:10.1002/mus.26821.

    PMID: 32012299
  16. 16

    Comparative study of peripheral nerve Mri and ultrasound in multifocal motor neuropathy and amyotrophic lateral sclerosis.

    Jongbloed BA, Haakma W, Goedee HS, et al.

    Muscle & nerve 2016; (54(6)):1133-1135 doi:10.1002/mus.25391.

    PMID: 27571543
  17. 17

    IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset.

    Budding K, Bos JW, Dijkxhoorn K, et al.

    Journal of neuroinflammation 2024; (21(1)):100 doi:10.1186/s12974-024-03090-y.

    PMID: 38632654
  18. 18

    Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment.

    Löscher WN, Oberreiter EM, Erdler M, et al.

    Journal of neurology 2018; (265(12)):2834-2840 doi:10.1007/s00415-018-9071-9.

    PMID: 30259176
  19. 19

    A population-based and cross-sectional study of the long-term prognosis in multifocal motor neuropathy.

    Al-Zuhairy A, Sindrup SH, Andersen H, Jakobsen J

    Journal of the peripheral nervous system : JPNS 2019; (24(1)):64-71 doi:10.1111/jns.12311.

    PMID: 30746851

This page is for informational purposes only and does not replace professional medical advice. Always consult your neurologist or healthcare provider for an accurate diagnosis and treatment plan regarding muscle weakness.

Get notified when new evidence is published on Multifocal motor neuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.